| Financier | Commitments |
|---|---|
| Borrower/Recipient | 19.15 |
| Healthy Lives, Nutrition and Population | 11.45 |
Primary Health Care Quality Improvement Program - Additional Financing
Abstract*
The proposed Additional Financing (component 2 – IPF ) for an amount of US$ 11.45 million will have two subcomponents that will contribute to the PDO while complementing and supporting Component 1 through goods and non-consulting services, as well as technical assistance (TA). Sub-component 2.1: Goods and services to strengthen the diagnostic and clinical capacity of PHC (US$ 9.05 million) will provide PHC organizations with basic diagnostic and clinical... Show More
Development Objective
The Program Development Objective is to contribute to improving the quality of primary health care services in the Kyrgyz Republic.
Key Details
Project Details
P178856
Active
Christel Vermeersch
Ministry of Finance
March 8, 2023
(as of board presentation)
June 21, 2023
N/A
US$ 636.24 million
Mandatory Health Insurance Fund,Ministry of Health
2023
US$ 11.45 million
N/A
Not Applicable
June 30, 2026
No
BANK APPROVED
March 28, 2024
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | N/A |
| IDA Commitment | N/A |
| IBRD + IDA Commitment | N/A |
| Lending Instrument | |
|---|---|
| Grant Amount | 11.45 |
| Total Project Cost** | 636.24 |
Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025
No data available.
Detailed Financial Activity as of March 31, 2025
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
PDO 1: Number of pregnant women who received hemoglobin test and urine analysis for bacteriuria during the first trimester in a public PHC, GPC, or SSES laboratory. Value 24000.00 6222.00 48000.00 Date December 31, 2018 December 31, 2021 December 31, 2025 Comment PDO 2: Number of patients with diabetes or suspected diabetes who receive an HbA1c test during the calendar year in a public PHC facility or the Republican Endocrinology Center Value 0.00 630.00 20000.00 Date December 31, 2018 December 31, 2021 December 31, 2025 Comment PDO 3: Increase in drug coverage for priority conditions under the ADP, as measured by number of prescriptions reimbursed for (i) Test strips, (ii) Iron supplements, and (iii) Hypertension drugs Value (i) 3,149 (ii) 169,480 (iii) 333,545 (i) 86,311; (ii) 783,889; (iii) 1,379,220 (i) 22,200 (ii) 1,224,000 (iii) 2,429,000 Date December 31, 2017 December 31, 2022 December 31, 2025 Comment PDO 4: A unit fully designated to quality improvement is established within the MoH and functioning Value No Yes Yes Date December 31, 2018 December 2, 2021 December 31, 2025 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
IRI 6 - The SGBP is revised to improve coverage for selected priority conditions at PHC. Value No revision. The PHC services and out-patient drug packages are Date December 31, 2018 December 31, 2021 December 31, 2025 Comment IRI 1- Number of online learning curricula on priority conditions and topics developed, approved, and available in the online CPD platform Value 0.00 8.00 20.00 Date December 31, 2018 December 31, 2022 December 31, 2025 Comment IRI 9 - Number of meetings by the Coordination Committee of the QI unit to discuss quality issues and actions Value 0.00 0.00 10.00 Date December 31, 2018 December 31, 2022 December 31, 2025 Comment IRI 7 - The PHC payment mechanism is revised. Value Capitation payment system does not incorporate adj Procedure classification for PHC is developed but At least one pay-for-quality mechanism complements Date December 31, 2018 December 31, 2022 December 31, 2025 Comment IRI 2 - Number of PHC physicians who complete at least one approved online PHC course with credit hours Value 0.00 70.00 900.00 Date December 31, 2018 March 31, 2023 December 31, 2025 Comment IRI 10 - Number of clinical guidelines revised or developed Value 0.00 1.00 30.00 Date December 31, 2018 November 8, 2022 December 31, 2025 Comment IRI 8 - The drugs list under the ADP program is revised to prioritize spending on evidence-based generic medications. Value No No Yes Date December 31, 2018 December 31, 2021 December 31, 2025 Comment Number of pregnant women who received hemoglobin test and urine analysis for bacteriuria during the first trimester in a public PHCfacility Value 24000.00 26871.00 270000.00 Date December 31, 2018 December 31, 2020 December 31, 2024 Comment IRI 11 - Number of PHC organizations receiving reports from the QI Unit on their own performance with benchmarking (at least twice in the calendar year) Value 0.00 0.00 79.00 Date December 31, 2018 December 31, 2022 December 31, 2025 Comment IRI 4 - Number of suspected or confirmed diabetic patients (type I or II) who received an HbA1C test in a public PHC facility or atthe Republican Endocrinology Center Value 0.00 630.00 20000.00 Date December 31, 2018 December 31, 2021 December 31, 2025 Comment IRI 12 - Number of PHC organizations whose Quality Committee receives training on quality improvement (at least once a year) Value 0.00 0.00 79.00 Date December 31, 2018 December 31, 2022 December 31, 2025 Comment IRI 13 - Number of PHC organizations that pilot a new mechanism to collect and process patient feedback and complaints. Value 0.00 0.00 15.00 Date December 31, 2018 December 31, 2022 December 31, 2025 Comment IRI 4.1 - Number of men Value 0.00 217.00 7000.00 Date December 31, 2018 December 31, 2021 December 31, 2025 Comment IRI 4.2 - Number of women Value 0.00 413.00 13000.00 Date December 31, 2018 December 31, 2021 December 31, 2025 Comment People who have received essential health, nutrition, and population (HNP) services Value 0.00 280813.00 1350000.00 Date December 31, 2018 December 31, 2020 December 31, 2024 Comment Number of children immunized Value 0.00 558314.00 1350000.00 Date December 31, 2018 December 31, 2021 December 31, 2024 Comment